possible risk of serious infection with the new rheumatoid arthritis drug, Enbrel (etanercept)
June 1999
The FDA is warning about a possible risk of serious infection with the new rheumatoid arthritis drug, Enbrel (etanercept). There are 30 reports of serious infections...including 6 deaths.
Enbrel works by binding tumor necrosis factor (TNF)...a protein that leads to joint pain and inflammation.
The problem is that TNF also helps fight infections.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote